Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$160.0M
-10.8% from 2023
Prescriptions
1.7M
$95.74 per claim
Patients
576K
240,322 prescribers
Total spending, 2024
$160.0M
$277.78 per patient
Medicare prescription drug plans paid $160.0M for Lidocaine in 2024, for 1,670,980 prescriptions and refills to 575,934 patients (down 10.8% from 2023). The average cost per claim was $95.74.
California had the highest Medicare cost for Lidocaine in 2024: $22.9M for 245,920 claims, followed by New York ($15.2M).
John K Kim, internal medicine in Annandale, VA, had the highest Medicare cost for Lidocaine in 2024: 1,576 claims costing $372K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| John K Kim Annandale, VA | Internal Medicine | 1,576 | 270 | $372K |
| Joo Y Jang Leonia, NJ | Nurse Practitioner | 1,362 | 230 | $254K |
| Young W Kang Duluth, GA |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 192,980 | 1,231,658 | 418,781 | $166.9M |
| 2023 | 213,530 | 1,377,826 | 480,779 | $179.4M |
| 2024 | 240,322 | 1,670,980 | 575,934 | $160.0M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 1,312 |
| 302 |
| $252K |
| Juli Kang Leonia, NJ | Nurse Practitioner | 1,217 | 232 | $220K |
| Heesoo Jeong Los Angeles, CA | Internal Medicine | 796 | 209 | $211K |
| Jiho Choi Annandale, VA | Family Practice | 1,003 | 434 | $209K |
| Shawn S Kim Duluth, GA | Internal Medicine | 699 | 178 | $177K |
| Vlad Nusinovich West Hollywood, CA | Internal Medicine | 1,522 | 163 | $173K |
| Sang H Baik Los Angeles, CA | Internal Medicine | 1,104 | 282 | $165K |
| Chang S Lee Flushing, NY | Internal Medicine | 1,163 | 177 | $155K |
| 1821106691 | General Practice | 1,700 | 420 | $154K |
| Jae Y Yoo Los Angeles, CA | Internal Medicine | 994 | 189 | $149K |
| Teresella M Gondolo Elmhurst, NY | Neurology | 476 | 187 | $134K |
| Stanley Kim Edison, NJ | Nephrology | 777 | 117 | $132K |
| Soo W Kang Buena Park, CA | Internal Medicine | 986 | 141 | $132K |
| Larry T Suk Gardena, CA | Internal Medicine | 548 | 100 | $128K |
| Mark Barats West Hollywood, CA | Nephrology | 882 | 100 | $123K |
| Shannon L Crawley Knoxville, TN | Nurse Practitioner | 868 | 176 | $119K |
| Amy L Blevins Knoxville, TN | Nurse Practitioner | 772 | 153 | $118K |
| Young-Jik Lee Los Angeles, CA | Internal Medicine | 916 | 199 | $111K |
| Sixto R Caro Brooklyn, NY | Internal Medicine | 367 | 85 | $108K |
| Alexander Pisaturo Birmingham, AL | Physical Medicine and Rehabilitation | 443 | 197 | $105K |
| Kyung M Han Los Angeles, CA | Internal Medicine | 650 | 182 | $103K |
| Jaesoo Pak Cerritos, CA | Internal Medicine | 493 | 58 | $101K |
| Eddie C Pyune Garden Grove, CA | Family Practice | 413 | 73 | $99K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Qualitest/Par P | 558,942 | $63.5M |
| Actavis/Teva TEVA | 359,277 | $41.9M |
| Amneal Pharmace AMRX | 225,916 | $22.8M |
| Yaral Pharma, I | 222,016 | $17.9M |
| Taro Pharm USA | 97,342 | $4.0M |
| Quagen Pharmace | 46,955 | $2.1M |
| Glenmark Pharma GLENMARK.NS | 47,513 | $1.6M |
| Northstar Rx Ll | 27,484 | $1.3M |
| Avkare | 7,511 | $1.3M |
| Macleods Pharma | 30,620 | $1.2M |
| Fougera/Sandoz SDZ.SW | 18,495 | $753K |
| Mylan VTRS | 6,630 | $713K |
| Alembic Pharmac | 9,111 | $426K |
| Teva-Novaplus TEVA | 4,703 | $408K |
| Strides Pharma STAR.NS | 5,851 | $215K |
| Ascend Laborato ALKEM.NS | 2,680 | $104K |
| Puretek Corpora | 214 | $27K |
| Ipg Pharmaceuti | 86 | $2,791 |
| IGI Labs, Inc./ | 96 | $1,668 |
| Teligent Pharma | 47 | $984 |